Marco Alings

11PUBLICATIONS
122CO-AUTHORS
Cardiology (incl. cardiovascular diseases)HaematologyElectrical energy generation (incl. renewables, excl. photovoltaics)Electrical circuits and systemsCircuits and systems
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 10, 2026
Blinded withdrawal of randomized treatment with low-dose digoxin or placebo in patients with heart failure: the DECISION trial.

|Aug 31, 2025
Cost-effectiveness of apixaban vs. aspirin for the reduction of thrombo-embolism in high-risk patients with device-detected atrial fibrillation: insights from the ARTESiA trial.

Andre Lamy, Roopinder K Sandhu, Wesley Tong

|Apr 25, 2025
Device-Related Complications in Transvenous Versus Subcutaneous Defibrillator Therapy During Long-Term Follow-Up: The PRAETORIAN-XL Trial.

Louise R A Olde Nordkamp, Jolien A de Veld, Abdul Ghani

|Dec 03, 2024
Inappropriate Therapy and Shock Rates Between the Subcutaneous and Transvenous Implantable Cardiac Defibrillator: A Secondary Analysis of the PRAETORIAN Trial.

Louise R A Olde Nordkamp, Shari Pepplinkhuizen, Abdul Ghani

|Nov 19, 2024
Quality of Life in Subcutaneous or Transvenous Implantable Cardioverter-Defibrillator Patients: A Secondary Analysis of the PRAETORIAN Trial.

Reinoud E Knops, Jolien A de Veld, Abdul Ghani

|Sep 04, 2024
Risk of Stroke or Systemic Embolism According to Baseline Frequency and Duration of Subclinical Atrial Fibrillation: Insights From the ARTESiA Trial.

William F McIntyre, Alexander P Benz, Jeff S Healey

Pageof 2

Frequent Collaborators

4 joint publications

Arthur A M Wilde

4 joint publications

David J Wright

3 joint publications

Christopher B Granger

3 joint publications

Jolien A de Veld